Differential activation in amygdala and plasma noradrenaline during colorectal distention by administration of corticotropin-releasing hormone between healthy individuals and patients with irritable bowel syndrome

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Tanaka, Yukari ^a,b   Kanazawa, Motoyori ^b   Kano, Michiko ^b   Morishita, Joe ^b   Hamaguchi, Toyohiro ^b   Van Oudenhove, Lukas ^c   Ly, Huynh Giao ^c   Dupont, Patrick ^d   Tack, Jan ^c   Yamaguchi, Takuhiro ^b   Yanai, Kazuhiko ^b   Tashiro, Manabu ^b   Fukudo, Shin ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; NORADRENALIN;

ADULT; AMYGDALA; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COLON DILATATION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRRITABLE COLON; MALE; NEUROIMAGING; NORADRENALIN BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; RIGHT HEMISPHERE; VISCERAL PAIN; BLOOD; CASE CONTROL STUDY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

AMYGDALA; CASE-CONTROL STUDIES; CORTICOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IRRITABLE BOWEL SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; POSITRON-EMISSION TOMOGRAPHY; VISCERAL PAIN; YOUNG ADULT;

EID: 84979709431     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157347     Document Type: Article

References (56)

1. Drossman DA. The functional gastrointestinal disorders and the rome iii process. Gastroenterology. 2006; 130:1377-90. PMID: 16678553
2. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther. 2003; 10:61-7. PMID: 12522523
3. Mikocka-Walus A, Turnbull D, Moulding N, Wilson I, Andrews JM, Holtmann G. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. J Gastroenterol Hepatol. 2008; 23:1137-43. PMID: 18070012
4. Blomhoff S, Spetalen S, Jacobsen MB, Malt UF. Phobic anxiety changes the function of brain-gut axis in irritable bowel syndrome. Psychosom Med. 2001; 63:959-65. PMID: 11719635
5. Whitehead WE, Crowell M, Robinson J, Heller B, Schuster M. Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992; 33:825-30. PMID: 1624167
6. Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med. 1987; 151:373-85. PMID: 3617051
7. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981; 213:1394-7. PMID: 6267699
8. Rivier C, Rivier J, Vale W. Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science. 1982; 218:377-9. PMID: 6289439
9. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992; 267:1244-52. PMID: 1538563
10. Fukudo S. Hypothalamic-pituitary-adrenal axis in gastrointestinal physiology. In: RJ L, editor. Physiology of the gastronintestinal tract. Oxford: Academic Press; 2012. pp 791-816.
11. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998; 42:845-9. PMID: 9691924
12. Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut. 2004; 53:958-64. PMID: 15194643
13. Tayama J, Sagami Y, Shimada Y, Hongo M, Fukudo S. Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2007; 19:471-83. PMID: 17564629
14. Hamaguchi T, Kano M, Rikimaru H, Kanazawa M, Itoh M, Yanai K, et al. Brain activity during distention of the descending colon in humans. Neurogastroenterol Motil. 2004; 16:299-309. PMID: 15198652
15. Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000; 118: 842-8. PMID: 10784583
16. Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain. 2005; 115:398-409. PMID: 15911167
17. Rapps N, van Oudenhove L, Enck P, Aziz Q. Brain imaging of visceral functions in healthy volunteers and ibs patients. J Psychosom Res. 2008; 64:599-604. doi: 10.1016/j.jpsychores.2008.02.018 PMID: 18501260
18. Hubbard CS, Labus JS, Bueller J, Stains J, Suyenobu B, Dukes GE, et al. Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain. J Neurosci. 2011; 31:12491-500. doi: 10.1523/JNEUROSCI. 1860-11.2011 PMID: 21880911
19. Fukudo S, Saito K, Sagami Y, Kanazawa M. Can modulating corticotropin releasing hormone receptors alter visceral sensitivity? Gut. 2006; 55:146-8. PMID: 16407379
20. Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos GP, Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology. 1996; 64:85-92. PMID: 8857602
21. Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Dirix S, et al. Regional brain activity in functional dyspepsia: a H(2)(15)O-PET study on the role of gastric sensitivity and abuse history. Gastroenterology. 2010; 139:36-47. doi: 10.1053/j.gastro.2010.04.015 PMID: 20406641
22. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130:1480-91. PMID: 16678561
23. Spielberger CD, Gorsuch RL, Lushene RE. Stai manual for the statetrait anxiety inventory. Palo Alto, CA, Consulting Psychologist Press; 1970.
24. Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the sds. Arch Gen Psychiatry. 1965; 13:508-15. PMID: 4378854
25. Suzuki H, Watanabe S, Hamaguchi T, Mine H, Terui T, Kanazawa M, et al. Brain activation associated with changes in heart rate, heart rate variability, and plasma catecholamines during rectal distention. Psychosom Med. 2009; 71:619-26. doi: 10.1097/PSY.0b013e31819b69ca PMID: 19561165
26. Williams CL, Peterson JM, Villar RG, Burks TF. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol. 1987; 253:G582-6. PMID: 2821826
27. Naliboff BD, Berman S, Suyenobu B, Labus JS, Chang L, Stains J, et al. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology. 2006; 131:352-65. PMID: 16890589
28. Labus JS, Naliboff BN, Fallon J, Berman SM, Suyenobu B, Bueller JA, et al. Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage. 2008; 41:1032-43. doi: 10.1016/j.neuroimage.2008.03.009 PMID: 18450481
29. Van Oudenhove L. Understanding gut-brain interactions in gastrointestinal pain by neuroimaging: Lessons from somatic pain studies. Neurogastroenterol Motil. 2011; 23:292-302. doi: 10.1111/j.1365-2982.2010.01666.x PMID: 21255193
30. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986; 42:121-30. PMID: 3719049
31. Dorn SD, Palsson OS, Thiwan SI, Kanazawa M, Clark WC, Van Tilburg MA, et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut. 2007; 56:1202-9. PMID: 17483191
32. Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology. 2011; 140: 91-100. doi: 10.1053/j.gastro. 2010.07.053 PMID: 20696168
33. Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist. 2004; 10:221-34. PMID: 15155061
34. LeDoux J. The amygdala. Curr Biol. 2007; 17:R868-74. PMID: 17956742
35. Petrovic P, Carlsson K, Petersson KM, Hansson P, Ingvar M. Context-dependent deactivation of the amygdala during pain. J Cogn Neurosci. 2004; 16:1289-301. PMID: 15453980
36. Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A. 2006; 103:6741-6. PMID: 16611726
37. Karst H, Berger S, Erdmann G, Schutz G, Joels M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A. 2010; 107:14449-54. doi: 10.1073/pnas.0914381107 PMID: 20663957
38. McEwen BS. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev. 2007; 87:873-904. PMID: 17615391
39. McEwen BS, Gianaros PJ. Central role of the brain in stress and adaptation: Links to socioeconomic status, health, and disease. Ann N Y Acad Sci. 2010; 1186:190-222. doi: 10.1111/j.1749-6632.2009.05331.x PMID: 20201874
40. Johnson LR, Hou M, Prager EM, Ledoux JE. Regulation of the fear network by mediators of stress: Norepinephrine alters the balance between cortical and subcortical afferent excitation of the lateral amygdala. Front Behav Neurosci. 2011; 5:23. doi: 10.3389/fnbeh.2011.00023 PMID: 21647395
41. Levine BS, Jarrett M, Cain KC, Heitkemper MM. Psychophysiological response to a laboratory challenge in women with and without diagnosed irritable bowel syndrome. Res nurs health. 1997; 20:431-41. PMID: 9334797
42. Posserud I, Agerforz P, Ekman R, Bjornsson ES, Abrahamsson H, Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut. 2004; 53: 1102-8. PMID: 15247175
43. Fukudo S. IBS: Autonomic dysregulation in IBS. Nat Rev Gastroenterol Hepatol. 2013; 10:569-71. doi: 10.1038/nrgastro.2013.166 PMID: 23999321
44. Vermeulen W, De Man JG, Pelckmans PA, De Winter BY. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol. 2014; 20:1005-20. doi: 10.3748/wjg.v20.i4.1005 PMID: 24574773
45. Su J, Tanaka Y, Muratsubaki T, Kano M, Kanazawa M, Fukudo S. Injection of corticotropin-releasing hormone into the amygdala aggravates visceral nociception and induces noradrenaline release in rats. Neurogastroenterol Motil. 2015; 27:30-9. doi: 10.1111/nmo.12462 PMID: 25359531
46. Rassnick S, Hoffman GE, Rabin BS, Sved AF. Injection of corticotropin-releasing hormone into the locus coeruleus or foot shock increases neuronal fos expression. Neuroscience. 1998; 85:259-68. PMID: 9607717
47. Conti LH, Foote SL. Effects of pretreatment with corticotropin-releasing factor on the electrophysiological responsivity of the locus coeruleus to subsequent corticotropin-releasing factor challenge. Neuroscience. 1995; 69:209-19. PMID: 8637619
48. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci. 1995; 15:6340-50. PMID: 7472399
49. Martins JM, Kastin AJ, Banks WA. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology. 1996; 63:338-48. PMID: 8739889
50. Esposito P, Gheorghe D, Kandere K, Pang X, Connolly R, Jacobson S, et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 2001; 888:117-27. PMID: 11146058
51. Banks WA. Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology. 2012; 153:4111-9. doi: 10.1210/en.2012-1435 PMID: 22778219
52. Bornstein SR, Chrousos GP (1999). Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTHmediated regulation of the adrenal cortex: Neural and immune inputs. J Clin Endocrinol Metab. 1999; 84:1729-36. PMID: 10323408
53. Videlock EJ, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M, et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology. 2009; 137:1954-62. doi: 10.1053/j.gastro.2009.08.058 PMID: 19737564
54. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002; 122:1140-56. PMID: 11910364
55. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012; 61: 1284-90. doi: 10.1136/gutjnl-2011-300474 PMID: 22234979
56. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology. 2006; 130:304-11. PMID: 16472586